News Daily News Radial Artery Best for Secondary Access During TAVI: PULSE Registry Michael O'Riordan December 23, 2024
News Conference News PCR London Valves 2024 Newest Sapien TAVI Equals Surgery in Patients With Small Aortic Annuli at 5 Years Michael O'Riordan November 27, 2024
News Conference News PCR London Valves 2024 Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice Michael O'Riordan November 25, 2024
Presentation AHA 2024 Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement Presenter: Chisato Izumi November 17, 2024
News Conference News AHA 2024 GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes Michael O'Riordan November 17, 2024
News Conference News AHA 2024 ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery Yael L. Maxwell November 17, 2024
News Conference News TCT 2024 Pooled All-Female Analysis Support Benefits of TAVI Over SAVR L.A. McKeown November 01, 2024
Presentation TCT 2024 TCT 653: Transcatheter or Surgical Aortic Valve Replacement Versus Clinical Surveillance in Asymptomatic Severe Aortic Stenosis: A Systematic Review and Meta-Analysis Presenter: Philippe Genereux October 30, 2024
News Conference News TCT 2024 ALIGN-AR at 2 Years Shows Promise for TAVI With Trilogy in Aortic Regurgitation Yael L. Maxwell October 29, 2024
Presentation TCT 2024 Transcatheter vs. Surgical Aortic Valve Replacement in Women: A Pooled Analysis of the RHEIA and PARTNER 3 Trials Presenter: Didier Tchetche October 29, 2024
Presentation TCT 2024 The ALIGN-AR Trial: Two-Year Outcomes of Transcatheter Aortic Valve Replacement With JenaValve TrilogyTM in High Surgical Risk Patients With Moderate-to-Severe or Severe Native Aortic Regurgitation Presenter: Torsten Vahl October 29, 2024
News Conference News TCT 2024 EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis Michael O'Riordan October 28, 2024
News Conference News TCT 2024 EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS L.A. McKeown October 28, 2024
Presentation TCT 2024 TCT 20: Utilization and Outcomes of Aortic Root Enlargement During Surgical Aortic Valve Replacement: Insights From the 2016-2021 National Inpatient Sample Database Presenter: Daniel Hanna October 28, 2024
Presentation TCT 2024 TCT 1541: Transcatheter Aortic Valve Replacement for Severe Aortic Valve Insufficiency in a 39-Year-Old Female With Complex Congenital Heart Disease and Prohibitive Surgical Risk: A Case Report Presenter: Marjolein Le October 28, 2024
Presentation TCT 2024 TCT 153: Surgical Bailout in Transfemoral Transcatheter Aortic Valve Replacement: Insights From a Contemporary TAVR Cohort During the COVID-19 Pandemic Presenter: Hugo Aarts October 28, 2024
Presentation TCT 2024 TCT 142: Time-Dependent Survival After Transcatheter Versus Surgical Aortic Valve Replacement: Results From the AUTHEARTVISIT Study Presenter: Johann Auer October 27, 2024
Presentation TCT 2024 TCT 141: Transcatheter Aortic-Valve Replacement (TAVR) Versus Surgical Aortic-Valve Replacement (SAVR) in Low-Risk Patients at Long Term Follow Up: Meta-Analysis of Randomized Controlled Trials Presenter: Sunny Goel October 27, 2024
Presentation TCT 2024 TCT 92: Early Transcatheter or Surgical Aortic Valve Replacement Versus Conservative Management in Asymptomatic Patients With Severe Aortic Stenosis: A Systematic Review and Meta-analysis Presenter: Avinash Nankani October 27, 2024